日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma

重新利用色瑞替尼可诱导 DNA 损伤并增强高级别浆液性卵巢癌的 PARP 抑制剂反应

Arun Kanakkanthara, Xiaonan Hou, Thomas L Ekstrom, Valentina Zanfagnin, Amelia M Huehls, Rebecca L Kelly, Husheng Ding, Melissa C Larson, George Vasmatzis, Ann L Oberg, Scott H Kaufmann, Aaron S Mansfield, S John Weroha, Larry M Karnitz

Intra-S phase checkpoint kinase Chk1 dissociates replication proteins Treslin and TopBP1 through multiple mechanisms during replication stress

期检查点激酶 Chk1 在复制压力期间通过多种机制分离复制蛋白 Treslin 和 TopBP1

Rebecca L Kelly, Amelia M Huehls, Annapoorna Venkatachalam, Catherine J Huntoon, Yuichi J Machida, Larry M Karnitz

DAGBagM: learning directed acyclic graphs of mixed variables with an application to identify protein biomarkers for treatment response in ovarian cancer

DAGBagM:学习混合变量的有向无环图及其在卵巢癌治疗反应蛋白质生物标志物识别中的应用

Chowdhury, Shrabanti; Wang, Ru; Yu, Qing; Huntoon, Catherine J; Karnitz, Larry M; Kaufmann, Scott H; Gygi, Steven P; Birrer, Michael J; Paulovich, Amanda G; Peng, Jie; Wang, Pei

Enzymatic activation of pyruvate kinase increases cytosolic oxaloacetate to inhibit the Warburg effect

丙酮酸激酶的酶促激活增加细胞浆草酰乙酸以抑制瓦堡效应

Elizabeth K Wiese, Sadae Hitosugi, Sharon T Loa, Annapoorna Sreedhar, Lindsey G Andres-Beck, Kiran Kurmi, Yuan-Ping Pang, Larry M Karnitz, Wilson I Gonsalves, Taro Hitosugi

Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer

多组学分析表明,CPT1A 是铂类耐药性高级别浆液性卵巢癌的潜在治疗靶点

Dongqing Huang ,Shrabanti Chowdhury ,Hong Wang ,Sara R Savage ,Richard G Ivey ,Jacob J Kennedy ,Jeffrey R Whiteaker ,Chenwei Lin ,Xiaonan Hou ,Ann L Oberg ,Melissa C Larson ,Najmeh Eskandari ,Davide A Delisi ,Saverio Gentile ,Catherine J Huntoon ,Uliana J Voytovich ,Zahra J Shire ,Qing Yu ,Steven P Gygi ,Andrew N Hoofnagle ,Zachary T Herbert ,Travis D Lorentzen ,Anna Calinawan ,Larry M Karnitz ,S John Weroha ,Scott H Kaufmann ,Bing Zhang ,Pei Wang ,Michael J Birrer ,Amanda G Paulovich

VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine Demethylases

VLX600通过抑制组蛋白赖氨酸去甲基化酶来破坏同源重组,并与PARP抑制剂和顺铂产生协同作用。

Thomas L Ekstrom ,Nicholas M Pathoulas ,Amelia M Huehls ,Arun Kanakkanthara # ,Larry M Karnitz #

ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancer

ZC3H18 特异性结合并激活 BRCA1 启动子,促进卵巢癌中的同源重组

Arun Kanakkanthara, Catherine J Huntoon, Xiaonan Hou, Minzhi Zhang, Ethan P Heinzen, Daniel R O'Brien, Ann L Oberg, S John Weroha, Scott H Kaufmann, Larry M Karnitz

BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents

BRCA1缺陷上调NNMT,从而重编程代谢并使卵巢癌细胞对线粒体代谢靶向药物敏感。

Arun Kanakkanthara,Kiran Kurmi,Thomas L Ekstrom,Xiaonan Hou,Emma R Purfeerst,Ethan P Heinzen,Cristina Correia,Catherine J Huntoon,Daniel O'Brien,Andrea E Wahner Hendrickson,Sean C Dowdy,Hu Li,Ann L Oberg,Taro Hitosugi,Scott H Kaufmann,S John Weroha,Larry M Karnitz

Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo

CHK1 抑制对 CPX-351 体外和体内细胞毒性的影响

Nicole D Vincelette, Husheng Ding, Amelia M Huehls, Karen S Flatten, Rebecca L Kelly, Mira A Kohorst, Jonathan Webster, Allan D Hess, Keith W Pratz, Larry M Karnitz, Scott H Kaufmann

Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway

线粒体肌酸激酶1的酪氨酸磷酸化增强了可药物靶向的肿瘤能量穿梭通路

Kiran Kurmi ,Sadae Hitosugi ,Jia Yu ,Felix Boakye-Agyeman ,Elizabeth K Wiese ,Thomas R Larson ,Qing Dai ,Yuichi J Machida ,Zhenkun Lou ,Liewei Wang ,Judy C Boughey ,Scott H Kaufmann ,Matthew P Goetz ,Larry M Karnitz ,Taro Hitosugi